Literature DB >> 12742900

WHO warns that death rate from SARS could reach 10%.

Jane Parry.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12742900      PMCID： PMC1125964          DOI： 10.1136/bmj.326.7397.999/a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

1.  Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain.

Authors:  Christopher E Yi; Lei Ba; Linqi Zhang; David D Ho; Zhiwei Chen
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

2.  Characterization of severe acute respiratory syndrome coronavirus genomes in Taiwan: molecular epidemiology and genome evolution.

Authors:  Shiou-Hwei Yeh; Hurng-Yi Wang; Ching-Yi Tsai; Chuan-Liang Kao; Jyh-Yuan Yang; Hwan-Wun Liu; Ih-Jen Su; Shih-Feng Tsai; Ding-Shinn Chen; Pei-Jer Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

3.  The occupational and psychosocial impact of SARS on academic physicians in three affected hospitals.

Authors:  Sherry L Grace; Karen Hershenfield; Emma Robertson; Donna E Stewart
Journal:  Psychosomatics       Date:  2005 Sep-Oct       Impact factor: 2.386

4.  Epidemiologic characteristics of SARS-CoV-2 in Wuhan, other regions of China, and globally based on data gathered from January 2020 to February 2021.

Authors:  Song Fengjiao; Li Xiaodong; Li Jian; Liu Hui
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

5.  Comparative Epidemiology of Human Infections with Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome Coronaviruses among Healthcare Personnel.

Authors:  Shelan Liu; Ta-Chien Chan; Yu-Tseng Chu; Joseph Tsung-Shu Wu; Xingyi Geng; Na Zhao; Wei Cheng; Enfu Chen; Chwan-Chuen King
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

6.  Receptor utilization of angiotensin-converting enzyme 2 (ACE2) indicates a narrower host range of SARS-CoV-2 than that of SARS-CoV.

Authors:  Qiong Wang; Ye Qiu; Jin-Yan Li; Ce-Heng Liao; Zhi-Jian Zhou; Xing-Yi Ge
Journal:  Transbound Emerg Dis       Date:  2020-09-05       Impact factor: 4.521

Review 7.  Epidemiological analysis of COVID-19 and practical experience from China.

Authors:  Qing Ye; Bili Wang; Jianhua Mao; Junfen Fu; Shiqiang Shang; Qiang Shu; Ting Zhang
Journal:  J Med Virol       Date:  2020-04-10       Impact factor: 20.693
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.